It is found that tumor cell‐free microparticles as an ideal vaccination platform can effectively transfer the tumor DNA fragment to DCs and lead to robust antitumor immunity, which is mediated by the cGAS‐STING signaling pathway.121. Here, STING1 is linked to neoplasm.